|
The balance of the RLNs at each reporting date is as follows:
|
|
|
|
|
|
|
September 30,
2025 |
|
Total liability related to the sale of future royalties, on inception |
|
$ |
10,990 |
|
Liability related to the sale of future royalties, arising from the 2020 Rights Offering |
|
|
51 |
|
Amortization of discount and debt issuance costs |
|
|
3,666 |
|
Adjustments to fair value |
|
|
(2,129 |
) |
Repayments |
|
|
(58 |
) |
Total liability related to the sale of future royalties at Sept 30, 2025 |
|
$ |
12,520 |
|
Current Portion |
|
|
281 |
|
Long-term Portion |
|
$ |
12,239 |
|
|
|
|
|
|
|
December 31, 2024 |
|
Total liability related to the sale of future royalties, on inception |
|
$ |
10,990 |
|
Liability related to the sale of future royalties, arising from the 2020 Rights Offering |
|
|
51 |
|
Amortization of discount and debt issuance costs |
|
|
3,666 |
|
Adjustments to fair value |
|
|
(3,936 |
) |
Total liability related to the sale of future royalties at December 31, 2024 |
|
$ |
10,771 |
|
Current Portion |
|
|
— |
|
Long-term Portion |
|
$ |
10,771 |
|
|